A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN

Clinical trial NCT04032093 · COMPLETED

Trial details

NCT number: NCT04032093
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Tract Infection

Start date: 2019-08-07
Primary completion: 2021-09-30
Enrollment: 1153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.